I. The Persistent Execution Gap in RWE Generation in Clinical Development We have previously articulated the case for systematic, integrated RWE generation beginning early in drug development -…

Life sciences organizations have long struggled with fragmented, time-intensive processes for discovering, assessing, and purchasing real-world data (RWD). These bottlenecks delay evidence generation, slow clinical and commercial decision-making,…

For life sciences organizations, medical record retrieval unlocks the “last mile” of real-world data (RWD) – providing access to complete, patient-level records that fill gaps left by traditional…

As digital health outpaces regulation, tokenization offers a scalable path to privacy and trust, enabling advancements that support regulatory, patient, and consumer priorities.

Datavant Life Sciences’ annual RWD Connect industry event brings together leaders from across our 350+ real-world data partners, including many of the world’s top 20 pharmaceutical companies, to…

As the healthcare data landscape continues to evolve and transform, the ability to discover and evaluate real-world data (RWD) with speed and precision is a critical advantage. For…

As the demand for high-quality real-world data (RWD) accelerates across the life sciences industry, so too does the urgency to solve the persistent friction in data discovery, access,…

In the high-stakes world of life sciences, where timelines are tight and data-driven decisions shape the success of therapies, time to insight can mean the difference between momentum…